Mingqiang Fu

1.2k total citations
37 papers, 855 citations indexed

About

Mingqiang Fu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Mingqiang Fu has authored 37 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Mingqiang Fu's work include Cardiovascular Function and Risk Factors (8 papers), Coronary Interventions and Diagnostics (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Mingqiang Fu is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Coronary Interventions and Diagnostics (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Mingqiang Fu collaborates with scholars based in China, Sweden and United States. Mingqiang Fu's co-authors include Yunzeng Zou, Junbo Ge, Aijun Sun, Chunyu Zhang, Juying Qian, Jingmin Zhou, Jingmin Zhou, Junbo Ge, Jianfeng Xu and Shuning Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Ethnopharmacology.

In The Last Decade

Mingqiang Fu

35 papers receiving 840 citations

Peers

Mingqiang Fu
Zhonghai Wei China
Shi Tai China
Eiji Yahiro Japan
Guoxian Qi China
Przemysław Leszek Poland
Chun Xi Liu China
Stefania Momi Italy
Thati Madhusudhan Germany
Elena Burillo Spain
Naifeng Liu China
Zhonghai Wei China
Mingqiang Fu
Citations per year, relative to Mingqiang Fu Mingqiang Fu (= 1×) peers Zhonghai Wei

Countries citing papers authored by Mingqiang Fu

Since Specialization
Citations

This map shows the geographic impact of Mingqiang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingqiang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingqiang Fu more than expected).

Fields of papers citing papers by Mingqiang Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingqiang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingqiang Fu. The network helps show where Mingqiang Fu may publish in the future.

Co-authorship network of co-authors of Mingqiang Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingqiang Fu. A scholar is included among the top collaborators of Mingqiang Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingqiang Fu. Mingqiang Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yan, et al.. (2025). Healthcare professionals' knowledge, attitude and practice towards ischemic bowel disease. World Journal of Gastrointestinal Surgery. 17(2). 96493–96493.
2.
3.
Li, Fuhai, Jingfeng Wang, Yu Song, et al.. (2021). Qiliqiangxin alleviates Ang II-induced CMECs apoptosis by downregulating autophagy via the ErbB2-AKT-FoxO3a axis. Life Sciences. 273. 119239–119239. 9 indexed citations
4.
Li, Fuhai, Mengying Xu, Mingqiang Fu, et al.. (2021). Increased ratio of sST2/LVMI predicted cardiovascular mortality and heart failure rehospitalization in heart failure with reduced ejection fraction patients: a prospective cohort study. BMC Cardiovascular Disorders. 21(1). 396–396. 1 indexed citations
5.
Xu, Rende, Shufu Chang, Qing Qin, et al.. (2021). Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization. Catheterization and Cardiovascular Interventions. 99(2). 226–233.
6.
Li, Fuhai, Mengying Xu, Yuyuan Fan, et al.. (2020). Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study. International journal of cardiac imaging. 36(4). 671–689. 17 indexed citations
7.
Wang, Yanyan, Mingqiang Fu, Jingfeng Wang, et al.. (2020). Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF‐1α‐Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction. BioMed Research International. 2020(1). 1276195–1276195. 14 indexed citations
8.
Qin, Qing, Shufu Chang, Rende Xu, et al.. (2019). Short and long-term outcomes of coronary perforation managed by coil embolization: A single-center experience. International Journal of Cardiology. 298. 18–21. 7 indexed citations
9.
Wang, Yanyan, Yuyuan Fan, Yu Song, et al.. (2019). Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathway. In Vitro Cellular & Developmental Biology - Animal. 55(10). 801–811. 14 indexed citations
10.
Xia, Yan, Zhangwei Chen, Ao Chen, et al.. (2017). LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy. Journal of Molecular and Cellular Cardiology. 108. 138–148. 115 indexed citations
11.
Wang, Jingfeng, Zhiming Li, Yanyan Wang, et al.. (2017). Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats. Evidence-based Complementary and Alternative Medicine. 2017(1). 3197320–3197320. 14 indexed citations
12.
Gao, Yanhua, Juying Qian, Zhangwei Chen, et al.. (2016). Suppression of Bim by microRNA-19a may protect cardiomyocytes against hypoxia-induced cell death via autophagy activation. Toxicology Letters. 257. 72–83. 31 indexed citations
13.
Xu, Jianfeng, Zheyong Huang, Li Lin, et al.. (2014). miRNA-130b is required for the ERK/FOXM1 pathway activation-mediated protective effects of isosorbide dinitrate against mesenchymal stem cell senescence induced by high glucose. International Journal of Molecular Medicine. 35(1). 59–71. 26 indexed citations
14.
Xu, Jianfeng, Zheyong Huang, Lin Li, et al.. (2014). miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation. Science China Life Sciences. 57(10). 989–997. 41 indexed citations
15.
Liu, Hongying, Dazhuo Shi, Wei Wang, et al.. (2012). Panax quinquefolium saponins inhibited immune maturation of human monocyte-derived dendritic cells via blocking nuclear factor-κB pathway. Journal of Ethnopharmacology. 141(3). 982–988. 13 indexed citations
16.
Xu, Jianfeng, Juying Qian, Xinxing Xie, et al.. (2012). High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways. Molecular and Cellular Biochemistry. 371(1-2). 55–64. 36 indexed citations
17.
Fu, Mingqiang, Jingmin Zhou, Juying Qian, et al.. (2012). Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study. Lipids in Health and Disease. 11(1). 106–106. 12 indexed citations
18.
Fu, Mingqiang, Jingmin Zhou, Aijun Sun, et al.. (2011). Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction — A meta analysis of 7 prospective clinical studies. International Journal of Cardiology. 155(1). 33–38. 43 indexed citations
19.
20.
Zhang, Chunyu, Aijun Sun, Peng Zhang, et al.. (2009). Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Research and Clinical Practice. 87(2). 211–218. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhonghai Wei Breakdown of academic impact, for papers by Shi Tai Breakdown of academic impact, for papers by Eiji Yahiro Breakdown of academic impact, for papers by Guoxian Qi Breakdown of academic impact, for papers by Przemysław Leszek Breakdown of academic impact, for papers by Chun Xi Liu Breakdown of academic impact, for papers by Stefania Momi Breakdown of academic impact, for papers by Thati Madhusudhan Breakdown of academic impact, for papers by Elena Burillo Breakdown of academic impact, for papers by Naifeng Liu
Rankless by CCL
2026